Good Active Ingredient NOAEL Data Sensitization Data

Climbazole

INCI: CLIMBAZOLE

CAS Number
38083-17-9
Function
Antifungal; anti-dandruff active; preservative
Safety Rating
GOOD

Regulatory Status

๐Ÿ‡ช๐Ÿ‡บ EU Status restricted
EU Max Conc. 2.0% rinse-off (anti-dandruff) / 0.5% rinse-off (preservative) / 0.2% leave-on (preservative)
๐Ÿ‡บ๐Ÿ‡ธ US Status permitted
US Notes Used as cosmetic anti-dandruff ingredient in the US; no OTC monograph inclusion

For full compliance data across 55 jurisdictions, use the Substance Compliance tool.

Safety Data

Margin of Safety (MoS)
adequate
Dermal Absorption
moderate
Sensitization
low

Calculate MoS for your specific formulation with the MoS Calculator.

Toxicological Studies

3 study endpoints found for Climbazole. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.

Endpoint Value Route Species Study Type Source
LOAEL 5 mg/kg bw/day oral rat Subchronic COSMOS_DB
NOAEL 45 mg/kg bw/day oral rat oral REACH
LOAEL 50 mg/kg bw/day oral rat oral REACH

SCCS NOAEL Values

NOAEL/LOAEL values cited in official SCCS opinions for Climbazole.

NOAEL LOAEL Route Species Study DA% (SCCS) Opinion
20 mg/kg/day 200 mg/kg/day Oral Rat Subchronic (90-day) (90 days) 100 SCCS/1506/13 (2013)

Sensitization Profile

Contact sensitization data for Climbazole based on clinical patch test studies and IFRA standards.

Sensitization Rate
low
Allergen Class
preservative
EU Allergen Listed
no
Patch Test Positive Rate
0.2%
Cross-reactivity Group
none
Reaction Type
contact-dermatitis

Source: ESSCA; IVDK; NACDG

Expert Verdict

EU-restricted imidazole antifungal with same ergosterol-inhibition mechanism as ketoconazole. SCCS/1600/18 confirmed safety at 2% rinse-off with adequate margin of safety accounting for 0.01 rinse-off retention factor. CoRAP evaluation for endocrine-disrupting potential is ongoing and could trigger future reclassification; monitor regulatory updates.

โš ๏ธ
Concern Level: Moderate

Regulatory Flags

eu-restricted antifungal endocrine-disruptor-suspected corap-evaluation malassezia-active eu_cosing_listed

Frequently Asked Questions

Is Climbazole safe in cosmetics?

EU-restricted imidazole antifungal with same ergosterol-inhibition mechanism as ketoconazole. SCCS/1600/18 confirmed safety at 2% rinse-off with adequate margin of safety accounting for 0.01 rinse-off retention factor. CoRAP evaluation for endocrine-disrupting potential is ongoing and could trigger future reclassification; monitor regulatory updates. The EU classifies Climbazole as "restricted". Safety rating: GOOD. 3 toxicological study endpoint(s) are available in our database.

Is Climbazole allowed in the EU?

Climbazole EU regulatory status: restricted. Maximum allowed concentration: 2.0% rinse-off (anti-dandruff) / 0.5% rinse-off (preservative) / 0.2% leave-on (preservative). This is based on EU Regulation 1223/2009 and its amendments.

What does Climbazole do in cosmetics?

Climbazole functions as: Antifungal; anti-dandruff active; preservative. It is classified as a Active Ingredient in our database. CAS number: 38083-17-9.

What is the Margin of Safety for Climbazole?

adequate The Margin of Safety (MoS) is calculated using SCCS methodology. A MoS above 100 is generally considered safe. Use the MoS Calculator tool to calculate MoS for your specific formulation and product category.

What is the NOAEL for Climbazole?

The NOAEL (No Observed Adverse Effect Level) for Climbazole is 5 mg/kg bw/day based on a Subchronic study via oral route in rat. A total of 3 study endpoints are available. Source: COSMOS_DB.

๐Ÿ“ฑ

Is Climbazole in Your Products?

Scan any product label with Piro โ€” our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.

Try Piro Free โ†’

Analyze Your Full Ingredient List

Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Climbazole in your formulation.